197 reports of this reaction
2.1% of all ZINC OXIDE reports
#13 most reported adverse reaction
PARAESTHESIA ORAL is the #13 most commonly reported adverse reaction for ZINC OXIDE, manufactured by MONAT GLOBAL CORP. There are 197 FDA adverse event reports linking ZINC OXIDE to PARAESTHESIA ORAL. This represents approximately 2.1% of all 9,433 adverse event reports for this drug.
Patients taking ZINC OXIDE who experience paraesthesia oral should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PARAESTHESIA ORAL is a less commonly reported adverse event for ZINC OXIDE, but still significant enough to appear in the safety profile.
In addition to paraesthesia oral, the following adverse reactions have been reported for ZINC OXIDE:
The following drugs have also been linked to paraesthesia oral in FDA adverse event reports:
PARAESTHESIA ORAL has been reported as an adverse event in 197 FDA reports for ZINC OXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PARAESTHESIA ORAL accounts for approximately 2.1% of all adverse event reports for ZINC OXIDE, making it a notable side effect.
If you experience paraesthesia oral while taking ZINC OXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.